T1	HMM 18 69	safety, immunogenicity, and pharmacokinetic profile
T2	HMM 512 583	safety and pharmacokinetics (serum concentrations of rabies antibodies)
T3	HMM 1474 1500	pharmacokinetic parameters
T4	HMM 1574 1598	relative bioavailability
T5	HMM 1622 1638	absorption rates
T6	HMM 1714 1728	antibody level
T7	HMM 1794 1827	geometric mean titer (GMT) values
T8	HMM 1985 2008	evolution of GMT values
T9	HMM 2240 2257	safety evaluation
T10	HMM 2304 2352	serum samples for anti-rabies antibody titration
T11	HMM 2417 2434	serious reactions
T12	HMM 2484 2560	immediate (anaphylactic type) or delayed (serum sickness) allergic reactions
T13	HMM 2610 2622	GMT profiles
T14	HMM 2705 2731	protective antibody titers
T15	HMM 2939 2949	GMT values
T16	HMM 3170 3188	antibody responses
